Tuesday, July 23, 2019

Pharmacy bodies welcome ‘clinically focused’ framework; concern on flat funding

The leading pharma bodies have welcomed the five-year funding framework but expressed concerns over a further five years of flat funding. The Royal Pharmaceutical Society...

New pharmacist consultation service offers £14 for completed consultation

A new pharmacy consultation service has been announced as part of the five-year Community Pharmacy Contractual Framework agreed today (22 July). The NHS Community Pharmacists Consultation Service,...
pharmacies

FIVE-YEAR deal for community pharmacies agreed with £13 billion funding boost

The government has today (22 July) agreed for a five-year contractual framework agreement for community pharmacies. The deal secures funding of almost £13 billion over...

Pharmacists warned of flu vaccine delivery delay

Deliveries of the standard quadrivalent flu vaccine will be delayed until November 2019, flu vaccine manufacturers said. They cited a delay of four weeks by...

DHSC publishes second list of July’s price concessions

The Department of Health and Social Care (DHSC) has announced its second list of price concessions for July. The announcement, revealed by the PSNC today,...

Two-thirds of Hypertension patients in Global South missing treatment: study

More than two-thirds of patients from low-and middle-income countries are missing treatment for high blood pressure or hypertension, according to a recent study. The study,...

Government renews Better Care Fund; allocates £6.4 billion

The government has decided to renew the Better Care Fund for 2019-20 with over £6.4 billion in pooled funding, ministers confirmed. The Better Care Fund,...

Drug-related deaths at all-time high in Scotland

Scotland registered 1,187 drug-related deaths in 2018, the largest number ever recorded, official data reveals. According to the latest report from National Records of Scotland, the...

LloydsPharmacy wins top award from Private Label Manufacturers Association

LloydsPharmacy Reusable Hot/Cold Pack, an own label product of McKesson Europe, has won the International Salute to Excellence Award from the Private Label Manufacturers...

Nice approves drug combination to delay breast cancer progression

Patients with advanced breast cancer can now access ribociclib with fulvestrant, a potential life-extending drug combination, through the Cancer Drugs Fund (CDF). The National Institute...